Desktop Broker TV

Interview Series 23rd February 2023

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara's journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
- (0:59) Becoming a Bell Potter Analyst
- (2:56) Approaches to analysing a company
- (7:18) Orthocell's global 25-year exclusive agreement
- (7:53) Orthocell's TGA approval for its Remplir device
- (8:44) Orthocell's speculative buy rating

Note: This interview was filmed on 7 February 2023.

View Part 2 Here!